NCT01513928View on ClinicalTrials.gov

A Study To Compare The Pharmacokinetics Of Different Formulations Of PF-04937319 In Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Healthy
Interventions
DRUG

Pf-04937319

Formulation A) Pf-04937319 50 mg - administered as tablet

DRUG

Pf-04937319

Formulation B) Pf-04937319 50 mg - administered as capsule

DRUG

Pf-04937319

Formulation C) Pf-04937319 50 mg - administered as capsule

Trial Locations (1)

188770

Pfizer Investigational Site, Singapore

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01513928 - A Study To Compare The Pharmacokinetics Of Different Formulations Of PF-04937319 In Healthy Subjects | Biotech Hunter | Biotech Hunter